Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1990 6
1991 21
1992 21
1993 31
1994 30
1995 29
1996 18
1997 24
1998 29
1999 23
2000 20
2001 28
2002 22
2003 30
2004 36
2005 37
2006 31
2007 69
2008 88
2009 149
2010 150
2011 192
2012 198
2013 282
2014 242
2015 229
2016 202
2017 151
2018 150
2019 60
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

2,314 results
Results by year
Filters applied: . Clear all
Page 1
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.
Quraishi MN, et al. Aliment Pharmacol Ther 2017 - Review. PMID 28707337 Free article.
BACKGROUND: Clostridium difficile infection (CDI) is the commonest nosocomial cause of diarrhoea. Faecal microbiota transplantation (FMT) is an approved treatment for recurrent or refractory CDI but there is uncertainty about its use. ...CONCLUSION: Faecal microbiota transplantation is an effective treatment for recurrent and refractory Clostridium difficile infection, independent of preparation and route of delivery....
BACKGROUND: Clostridium difficile infection (CDI) is the commonest nosocomial cause of diarrhoea. Faecal microbiota transplant …
Clostridium difficile Infection.
Bartlett JG. Infect Dis Clin North Am 2017 - Review. PMID 28779831
Clostridium difficile infection is a major health care challenge in terms of patient and economic consequences. For the patient, it is a morbid and sometimes a life-threatening iatrogenic complication of antibiotic treatment. ...
Clostridium difficile infection is a major health care challenge in terms of patient and economic consequences. For the patien
Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
Manthey CF, et al. Expert Rev Clin Pharmacol 2017 - Review. PMID 28766951
Infections with Clostridium difficile (CDI) represent a major burden for the health care system. Treatment is generally by antibiotic therapy with metronidazole and vancomycin, but efficacy remains suboptimal. ...We performed a systematic literature review using the search terms 'Clostridium difficile' and 'treatment'....
Infections with Clostridium difficile (CDI) represent a major burden for the health care system. Treatment is generally by ant …
Clostridium difficile. A review on an emerging infection.
Del Prete R, et al. Clin Ter 2019 - Review. PMID 30789196 Free article.
Clostridium difficile causes antibiotic-associated diarrhoea and pseudomembranous colitis. The main virulence factors of C. difficile are the toxins A (TcdA) and B (TcdB). ...C. difficile has spread around world. Clostridium difficile infection (CDI) is one of the most common health-care associated infections and a significant cause of morbidity and mortality among older adult hospitalized patients. ...
Clostridium difficile causes antibiotic-associated diarrhoea and pseudomembranous colitis. The main virulence factors of C.
Present and past perspectives on Clostridium difficile infection.
Álvarez-Hernández DA, et al. Rev Gastroenterol Mex 2018. PMID 28684034 Free article.
Clostridium difficile is a Gram-positive bacillus that has become one of the main hospital-acquired human gastrointestinal infections in recent years. ...The present article is a review of the epidemiologic, pathophysiologic, diagnostic, and therapeutic aspects of C.difficile infection, from its first isolation to the present date, that aims to contribute to the preparation of general physicians and specialists, so that patients with this infection receive opportune and quality medical attention....
Clostridium difficile is a Gram-positive bacillus that has become one of the main hospital-acquired human gastrointestinal inf
Clostridium difficile control measures: current and future methods for prevention.
Mejia-Chew C and Dubberke ER. Expert Rev Anti Infect Ther 2018 - Review. PMID 29353504
Clostridium difficile is the most common cause of healthcare associated infection, and C. difficile infection (CDI) is associated with significant costs, morbidity, and mortality. ...Areas covered: Evidence of the interventions recommended by international scientific societies will be reviewed, as well as ongoing research on new strategies, such as screening for asymptomatic C. difficile carriage, microbiota sparing agents, bacteriocins and vaccines. ...
Clostridium difficile is the most common cause of healthcare associated infection, and C. difficile infection (CDI) is
European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection.
Crobach MJ, et al. Clin Microbiol Infect 2016. PMID 27460910 Free article.
In 2009 the first European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guideline for diagnosing Clostridium difficile infection (CDI) was launched. ...
In 2009 the first European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guideline for diagnosing Clostridium
Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea.
Dubberke ER, et al. Infect Control Hosp Epidemiol 2018. PMID 30226126 Free PMC article.
OBJECTIVE: To determine the prevalence of Clostridium difficile colonization among patients who meet the 2017 IDSA/SHEA C. difficile infection (CDI) Clinical Guideline Update criteria for the preferred patient population for C. difficile testing. ...The prevalence of toxigenic C. difficile colonization among EIA- patients who met the IDSA/SHEA CDI guideline criteria for preferred patient population for C. difficile testing was 12%....
OBJECTIVE: To determine the prevalence of Clostridium difficile colonization among patients who meet the 2017 IDSA/SHEA C. …
Clostridium difficile presence in Spanish and Belgian hospitals.
Rodriguez C, et al. Microb Pathog 2016. PMID 27616443 Free article.
Clostridium difficile is recognised worldwide as the main cause of infectious bacterial antibiotic-associated diarrhoea in hospitals and other healthcare settings. ...This study finds that the presence and detection of C. difficile in paediatric and oncology services requires further investigation....
Clostridium difficile is recognised worldwide as the main cause of infectious bacterial antibiotic-associated diarrhoea in hos
A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients.
Shogbesan O, et al. Can J Gastroenterol Hepatol 2018. PMID 30246002 Free PMC article.
BACKGROUND: Fecal microbiota transplantation (FMT) has been shown to be effective in recurrent Clostridium difficile (CD) infection, with resolution in 80% to 90% of patients. ...
BACKGROUND: Fecal microbiota transplantation (FMT) has been shown to be effective in recurrent Clostridium difficile (CD) infe …
2,314 results
Jump to page
Feedback